Home » Newsletters » BioWorld Science

BioWorld Science

May 12, 2022

View Archived Issues

Inflammation is key to preventing chronic pain, study finds

Microglial MIR155 targeting ameliorates vasculopathy in retina of AD models

Loss of angpt1 recapitulates glaucoma features

Kumquat Biosciences patents SOS1/KRAS interaction inhibitors

Sichuan Haisco Pharmaceutical divulges new JAK inhibitors

Rheos Medicines identifies new MALT1 inhibitors

Gilead Sciences presents new compounds for viral infections

New PROTACs presented by C4 Therapeutics

PEGylation of bispecific antibody IGT-427 improves potential for treating retinal diseases

Targeting bromodomain in Brg-1 unveiled as a promising approach for uveal melanoma

GT-02329 shows promise in in vitro and in vivo Gaucher disease models

Myrtelle launches new research program for Pelizaeus-Merzbacher disease

CRB-601 shows promising antitumor activity alone or in combination with immunotherapy

Aro's Centyrin-targeted siRNA conjugates show potential for Pompe disease

Inimmune develops TLR7/8 agonist for monotherapy or combination with anti-PD-1 therapy

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Cosmo data positive for first new hair-loss approach in decades
BioWorld
Shares of Cosmo Pharmaceuticals NV rose sharply on Dec. 3 following top-line pivotal phase III data showing a statistically significant and clinically meaningful...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...